Benitec Biopharma Inc (BNTC)

NASDAQ

$11.97

Benitec Biopharma Inc., a developing biotechnology company, is focused on the development of new genetic drugs. The company is headquartered in Hayward, California.

Website: https://benitec.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Buy

Target: $25.80 (+115.54%)

Market Cap

$447M

Free Cash Flow Yield

-4.43%

Beta (5Y)

0.76

Price Chart

Adjust inflation

Log

Valuation

Market Cap$447M

P/S2770.13

P/B2.43

Profitability

EBITDA-$47M

EPS-$1.37

Financial Health

Free Cash Flow Yield-4.43%

Growth & Risk

FCF 5Y CAGR+12.10%

Beta (5Y)0.76

Sharpe Ratio0.27